Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure

A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review

(2016) Mark Bloch et al.   CLINICAL INFECTIOUS DISEASES

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

(2015) Willemijn J. Jansen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients

(2015) M. A. M. Janssen et al.   JOURNAL OF NEUROVIROLOGY

Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging

(2014) Michelle M. Mielke et al.   Alzheimers & Dementia

HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research

(2014) Lucette A. Cysique et al.   JOURNAL OF NEUROVIROLOGY

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline

(2014) I. Grant et al.   NEUROLOGY

Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS

(2013) Amy R. Zipursky et al.   AIDS

A Systematic Review of the Screening Accuracy of the HIV Dementia Scale and International HIV Dementia Scale

(2013) Lewis John Haddow et al.   PLoS One

Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide

(2013) Jody Kamminga et al.   Current HIV/AIDS Reports

Defining Neurocognitive Impairment in HIV: Deficit Scores Versus Clinical Ratings

(2012) K. Blackstone et al.   CLINICAL NEUROPSYCHOLOGIST

Concurrent Classification Accuracy of the HIV Dementia Scale for HIV-Associated Neurocognitive Disorders in the CHARTER Cohort

(2012) Maiko Sakamoto et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study

(2012) Yen Ying Lim et al.   JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY

Facial emotional processing in HIV infection: Relation to neurocognitive and neuropsychiatric status.

(2012) Tammy A. Lane et al.   NEUROPSYCHOLOGY

Identification of an Abbreviated Test Battery for Detection of HIV-Associated Neurocognitive Impairment in an Early-Managed HIV-Infected Cohort

(2012) David J. Moore et al.   PLoS One

Concurrent Validity of a Computer-Based Cognitive Screening Tool for Use in Adults with HIV Disease

(2011) James T. Becker et al.   AIDS PATIENT CARE AND STDS

Screening for Cognitive Impairment in Human Immunodeficiency Virus

(2011) V. Valcour et al.   CLINICAL INFECTIOUS DISEASES

A neuropsychological investigation of multitasking in HIV infection: Implications for everyday functioning.

(2011) J. Cobb Scott et al.   NEUROPSYCHOLOGY

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia

(2010) Samanta Simioni et al.   AIDS

A screening algorithm for HIV-associated neurocognitive disorders

(2010) LA Cysique et al.   HIV MEDICINE

Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex

(2009) P. Maruff et al.   ARCHIVES OF CLINICAL NEUROPSYCHOLOGY

Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy

(2009) S Skinner et al.   HIV MEDICINE